$KYMR
Kymera Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$106.80
▼-1.43%-$1.55
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateKymera Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is KYMR down today? It is at $106.80 (-1.43%), and our scanner flagged it 80 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment KYMR spikes, and full due diligence on KYMR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $KYMR 80 times in the last 30 days. Create a free account to track $KYMR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
KYMR is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 5 unusual-volume and momentum alerts on KYMR today, peaking at 13.4x its normal volume.
Likely catalystKymera Therapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Oct 1, 2026 · 6 days agoThe company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
62,770,158 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $500.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Mainolfi Nello Officer | Sold (automatic/other) | -30K 0.04% of company | sold 4.3% | 667K | $3.3M at $111.44 | Oct 1, 26 |
Mainolfi Nello Officer | Other | 30K 0.04% of company | added 4.5% | 697K | $62K at $2.08 | Oct 1, 26 |
Adams Brian Officer | Sold (automatic/other) | -6K | sold 11% | 50K | $736K at $115.55 | Sep 4, 26 |
Rooney Terence Officer | Acquired (grant/award) | +38K 0.05% of company | n/a | 38K | n/a | Jul 27, 26 |
Mainolfi Nello Officer | Sold (automatic/other) | -50K 0.06% of company | sold 7.0% | 667K | $6.0M at $119.00 | Jul 7, 26 |
Mainolfi Nello Officer | Other | 50K 0.06% of company | added 7.5% | 717K | $104K at $2.08 | Jul 7, 26 |
Goodman Noah Officer | Sold (automatic/other) | -3K | sold 6.7% | 47K | $387K at $114.29 | Jul 1, 26 |
Mainolfi Nello Officer | Sold (automatic/other) | -80K 0.10% of company | sold 11% | 667K | $9.0M at $112.80 | Jul 1, 26 |
Mainolfi Nello Officer | Other | 80K 0.10% of company | added 12% | 747K | $166K at $2.08 | Jul 1, 26 |
Jacobs Bruce N. Officer | Sold (automatic/other) | -77K 0.09% of company | sold 24% | 245K | $8.5M at $110.54 | Jun 30, 26 |
Jacobs Bruce N. Officer | Other | 61K 0.07% of company | added 24% | 322K | $327K at $5.33 | Jun 30, 26 |
Booth Bruce Director | Sold (automatic/other) | -45K 0.05% of company | sold 1.6% | 2.88M | $4.8M at $105.78 | Jun 29, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
KYMR is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 5 unusual-volume and momentum alerts on KYMR today, peaking at 13.4x its normal volume.
KYMR last traded at $106.80, down 1.43% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Kymera Therapeutics, Inc. Common Stock (KYMR) is next expected to report earnings on Tuesday, November 3, 2026, about 26 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The KYMR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged KYMR 80 times in the last 30 days.
KYMR (Kymera Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $9.01B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge KYMR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$KYMR discussion
Sign in to ask a question or join the discussion.